The Efficacy of Pramipexole, a Dopamine Receptor Agonist, as an Adjunctive Treatment in Treatment-Resistant Depression: An Open-Label Trial

Dopaminergic dysfunction is implicated in the pathophysiology of treatment-resistant depression. Although the efficacy of adjunctive pramipexole treatment has been demonstrated in treatment-resistant bipolar depression, such data are scarce for major depressive disorder (MDD). We recruited 17 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Hori, Hiroaki, Kunugi, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415165/
https://www.ncbi.nlm.nih.gov/pubmed/22919308
http://dx.doi.org/10.1100/2012/372474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415165/
https://www.ncbi.nlm.nih.gov/pubmed/22919308
http://dx.doi.org/10.1100/2012/372474

Ejemplares similares